Japanese Packaging Stock News

SAMCO (TSE:6387) has released its H1 2026 scorecard, posting revenue of ¥4,587 million and basic EPS of ¥93.50, with net income excluding extra items at ¥751 million setting the tone for the latest update. The company has seen revenue move from ¥4,121 million with EPS of ¥88.89 in H1 2025 to ¥5,221 million and EPS of ¥122.39 in H2 2025, and trailing twelve month figures now sit at ¥9,808 million of revenue and EPS of ¥215.88, giving you a clear run rate to compare against the current half...

3-D Matrix (TSE:7777) has just posted its Q3 2026 scorecard, with revenue of ¥2,539 million and net income of ¥653 million, translating to basic EPS of ¥5.39. The company has seen quarterly revenue range from ¥1,875 million in Q4 2025 to ¥2,613 million in Q2 2026, while basic EPS has swung from a loss of ¥10.11 in Q4 2025 to a gain of ¥7.96 in Q2 2026 and ¥5.39 this quarter. This reflects a move from losses to profits over the recent reporting periods. For investors, that combination of...

Nidec (TSE:6594) is back in focus after its board resolved to skip the year end dividend for the fiscal year ending March 2026, following a Third Party Committee report on inappropriate accounting treatment. See our latest analysis for Nidec. The latest decision to skip the year end dividend comes on top of a 14.96% 3 month share price return and a 10.56% year to date share price return. At the same time, the 1 year total shareholder return of 13.24% and 5 year total shareholder return of...

In March 2026, Daiichi Sankyo and AstraZeneca announced that the U.S. FDA accepted and granted Priority Review to their supplemental Biologics License Application for ENHERTU, targeting adults with HER2 positive breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. The application rests on DESTINY-Breast05 phase 3 data showing ENHERTU cut the risk of invasive disease recurrence or death versus T-DM1, with three-year invasive disease-free survival of...

If you are wondering whether Nissan Motor's current share price reflects its true worth, you are not alone, many investors are asking the same question as they reassess the stock. The shares recently closed at ¥381.4, with a 2.1% gain over the last 7 days contrasting with a 6.8% decline over 30 days and a 10.2% decline over 1 year, which can change how investors think about both upside and risk. Recent headlines around Nissan often focus on its position in the global auto sector and how it...

Toyota Tsusho Corporation recently held a board meeting on March 3, 2026, approving an absorption-type company split that transfers part of its Sustainable Materials business to Toyotsu Chemiplas Corporation, following an earlier January 14, 2026 meeting to consider the purchase price in a repurchase tender offer. This reshaping of the Sustainable Materials portfolio highlights how Toyota Tsusho is actively reconfiguring its operations to refine focus within its broader chemicals and...

If you are wondering whether Advantest is priced for perfection or still offers value, you are not alone. This article focuses on what the current share price might be implying. The stock has been volatile recently, with a 4% decline over the last 7 days and an 11.4% decline over the last 30 days, set against a 15.8% gain year to date and a very large 1 year return of 214.6% and around 7x over 3 years. Those moves have kept Advantest on many investors' watchlists, as they reassess what such...

Taisei Corporation announced at its February 26, 2026 board meeting that Member of the Board Junichi Kasahara will become Representative Director on April 1, 2026, alongside a broad reshuffle of executive roles and the retirement of several Executive Vice Presidents into counsellor positions. The transition keeps outgoing Representative Director Masahiko Okada on the board while elevating long-serving internal talent to key operational posts, signaling an internal rebalancing of leadership...

Recent share performance and what it might signal Hino Motors (TSE:7205) has been under pressure recently, with the share price showing a 2.5% decline over the past day and a 5.7% decline over the past week, extending weakness over the past month. For investors watching shorter term moves, that month performance lines up with a 15.8% decline, while the past 3 months show a 2.1% total return and the past year reflects a 16.3% total return decline. See our latest analysis for Hino Motors. With...

Event driven snapshot of Toray Industries Toray Industries (TSE:3402) has drawn fresh attention after a period where the share price showed mixed short term moves alongside positive longer term total returns, prompting investors to reassess the stock’s recent performance and valuation. See our latest analysis for Toray Industries. At a share price of ¥1,189.5, Toray Industries has experienced short-term share price softness, including a 5.26% 1-month share price return. This contrasts with...

On March 5, 2026, Sysmex Corporation’s board approved a share repurchase program of up to 30,000,000 shares, or 4.81% of its issued share capital, for ¥30,000 million, with all repurchased shares to be cancelled by September 18, 2026. An interesting aspect of this move is the company’s explicit goal of pairing higher capital efficiency and shareholder returns with continued investment in future business growth. We’ll now examine how the planned cancellation of repurchased shares could shape...

Hokkaido Electric Power Company (TSE:9509) has updated its Ishikariwan Shinko Power Station plan, lifting the planned output for Unit 2 to 580,000 kW and bringing construction forward to August 2026. See our latest analysis for Hokkaido Electric Power Company. The updated Ishikariwan Shinko plan comes after a mixed price patch, with a 1 day share price return of 2.01% lifting the stock to ¥1,063.5, while the year to date share price return is 3.32% lower and the 1 year total shareholder...

Eisai has announced that it will present new long-term data on its Alzheimer’s drug lecanemab, including four-year results from the Clarity AD Open-Label Extension trial and real-world safety and efficacy findings in specific patient groups, at the AD/PD 2026 conference held in March 2026. This wave of extended and real-world lecanemab data, plus Eisai’s prominent role hosting an industry symposium, sharpens attention on how thoroughly the drug could reshape Alzheimer’s treatment...

In recent days, SoftBank Group has sought a loan of up to US$40.00 billion to support its OpenAI investment, while subsidiary PayPay prepared an American IPO of about US$1.00 billion targeting a valuation near US$13.40 billion, all against a backdrop of conflict-linked oil price spikes and global market stress. These developments highlight the tension between SoftBank’s push into AI and fintech platforms and the heightened macro risk facing highly leveraged, market-sensitive technology...

If you are wondering whether Sony Group shares offer good value right now, or if you might be better off waiting for a clearer entry point, this article is designed to help you frame that question using numbers rather than headlines. The stock last closed at ¥3,431, with recent returns mixed: around 1.2% over 7 days, a 0.7% decline over 30 days, a 15.9% decline year to date, and 3.1% over 1 year, while the 3 year and 5 year returns sit at 62.0% and 60.3% respectively. Recent coverage around...

In February 2026, Yodoko, Ltd. raised its year-end dividend forecast to ¥69.00 per share and significantly increased its consolidated and non-consolidated earnings guidance for the fiscal year ending March 31, 2026, after a 1-for-5 share split in July 2025. The sharp upward revision in profit forecasts, especially the jump in expected profit attributable to owners of parent and corresponding earnings per share, signals a stronger earnings outlook and enhanced emphasis on shareholder...

BEAUTY GARAGE (TSE:3180) has put up another quarter of steady top and bottom line figures, with Q3 2026 revenue at ¥9.4 billion and basic EPS of ¥16.42, giving investors a clear read on the latest run rate. The company has seen revenue move from ¥8.3 billion in Q2 2025 to ¥9.4 billion in Q3 2026, while quarterly basic EPS has ranged from ¥15.66 in Q2 2025 to ¥16.42 in the latest quarter, setting the backdrop for how you might think about its earnings power and the current release. With...

Mitsubishi (TSE:8058) is back in focus after Frontier Lithium announced a new non binding MoU with Panasonic Energy and Mitsubishi on potential lithium salts procurement linked to the PAK Lithium Project in Ontario. See our latest analysis for Mitsubishi. The lithium MoU lands at a time when Mitsubishi’s share price has been strong, with a 40.2% 3 month share price return and a 42.81% year to date share price return. The 1 year total shareholder return of 108.86% and 5 year total shareholder...

BANDAI NAMCO Holdings Inc. previously reported nine-month results to December 31, 2025, with sales of ¥1,002,243 million and net income of ¥115,044 million, while also cutting full-year dividend guidance for the year ending March 31, 2026 to ¥50 per share from ¥60 a year earlier. Alongside these updates, the board scheduled a March 6, 2026 meeting to consider purchasing treasury shares, highlighting an active approach to capital allocation despite reduced shareholder payouts. We’ll now...

Shizuoka Financial GroupInc (TSE:5831) is back in focus after a recent shelf registration for up to ¥300b in bonds, together with a board meeting to consider acquiring treasury stock and other capital management items. See our latest analysis for Shizuoka Financial GroupInc. The bond shelf registration and planned treasury stock discussions come after a mixed few weeks for the share price. A 4.06% 1 day share price return contrasts with a 6.58% 7 day decline and an 8.22% year to date gain...

Mizuho Financial Group has recently completed the issuance of two tranches of fixed-to-floating rate perpetual, subordinated, unsecured notes totaling ¥190 billion, alongside board approval to repurchase common stock and an extensive refresh of its senior leadership and board structure. This combination of new subordinated capital and leadership reshaping highlights an effort to refine the group’s capital structure and governance framework at the same time. We’ll now examine how the new...

In early March 2026, Japan’s stock market dropped sharply on inflation concerns as oil prices moved above US$100 per barrel, pressuring sectors including semiconductors, metals, and wires and weighing on Tokyo Electron. The sell-off eased somewhat after reports that G7 countries were discussing a coordinated release of oil reserves, highlighting how policy responses can quickly influence sentiment toward economically sensitive semiconductor equipment makers like Tokyo Electron. We’ll now...

Activist pressure puts HORIBA in the spotlight Oasis Management, which owns 9.90% of HORIBA (TSE:6856), has urged shareholders to vote against the reappointment of Chairman Atsushi Horiba at the 2026 AGM, sharply criticizing past acquisitions and governance. See our latest analysis for HORIBA. The activist campaign lands at a time when HORIBA’s share price has shown strong momentum, with a 21.6% 90 day share price return and a 100.3% 1 year total shareholder return pointing to shifting...

FUJIFILM Holdings (TSE:4901) is back in focus after VolitionRx completed validation of an automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems in Japan, expanding automated canine cancer screening capacity across its laboratory network. See our latest analysis for FUJIFILM Holdings. The ¥3,017 share price comes after a mixed run, with a 1 day share price return of 1.67% set against a 90 day share price decline of 10.32% and a 1 year total shareholder return of 1.20%. Recent momentum looks...